voice search
Letrozoletablets Letroz - Drug Type: General Medicines

Letrozoletablets Letroz - Drug Type: General Medicines

Price: 168.00 INR / Pack

(150.00 INR + 12% GST)

Get Latest Price

MRP:

200.00 INR / Unit

Weight :

60.00 Gram

1 Pack Contains :

10

Minimum Pack Size :

200

In Stock

In Stock

-200+

Product Specifications

Drug TypeGeneral Medicines
Physical FormTablets
Dosage GuidelinesAs per suggestion
Storage InstructionsDry Place
FOB PortMumbai Urban
Payment TermsCash in Advance (CID), Cheque, Paypal, Telegraphic Transfer (T/T)
Supply Ability1000 Per Month
Delivery Time7 Days
Sample PolicyFree samples are available
Packaging Details1 VIAL
Main Export Market(s)Asia, Australia, Middle East, Africa
Main Domestic MarketAll India
CertificationsCOA , GMP
GSTIN12%
ReturnableNo
Packsize10
Product Unit200 Unit/Units
Stock Quantity1000
CurrencyINR
Pkg Box Height3.00 cm
Shipping Typefree
Pkg Box Breadth5.00 cm
Unit TypeUnit/Units
Brand NameLETROZ
Moq200
Weight60.00 Gram
Pkg Box Length12.00 cm
Price Typefixed
Mop200
MRP200.00 INR
Price150.00 INR (Approx.)
Minimum Order Quantity200
Minimum Ordered Packs200

Company Details

Parshva Agency is a notable supplier and trader of anti-cancer medicine, antidiabetic medicine, hormone therapy medicine, anti-HIV medicine, skin cream, pharmaceutical vaccine medicine, anti-bacterial medicine, etc. Established in 2010, we have become a dependable and respectable organisation in the domain of medicine. With strong business links with reputed MNCs in the market, we have been serving the demands of wholesalers, merchants, medical clinics, retail drug stores, NGOs, etc. Our vendors have modern manufacturing facilities with WHO-GMP certifications to ensure they meet high quality standards.

Business Type

Exporter, Supplier, Trading Company

Employee Count

10

Establishment

2010

Working Days

Monday To Sunday

GST NO

27AAAPR8475Q1ZQ

Payment Mode

Western Union, Paypal, Others

Related Products

Explore Related Categories

More Products From This Seller

Seller Details

GST

GST - 27AAAPR8475Q1ZQ

Trusted SellerTrustedSeller
Premium Seller

Mumbai, Maharashtra

Proprietor

Mr Hiren

Members since

3 Years

Address

No. A-108, 1st Floor, Sussex Industrial Estate, D.k. Cross Road, Byculla East, Mumbai, Maharashtra, 400027, India

letrozole tablet in Mumbai

Report incorrect details

Compare With Similar Products

Buyer Feedback

3

4

Response Rate

3.12

0.27

Minimum Order Quantity

200 Pack/Packs

10 Box/Boxes

100 Piece/Pieces

Price Or Price Range

150 INR

25.96-28.70 USD

193.51 INR

Physical Form

Drug Type

Storage Instructions

Dry Place

ROOM TEMP. 10 -30 C

Keep Dry Place

Supply Ability

1000 Per Month

100 Per Week

1000 Per Week

Delivery Time

7 Days

2 Week

1 Week

Payment Terms

Telegraphic Transfer (T/T)

Cash in Advance (CID)

Cash in Advance (CID)

Main Domestic Market

All India

All India

All India

Sample Policy

Free samples are available

Contact us for information regarding our sample policy

Certifications

COA , GMP

ISO 9001 TO 20015

FOB Port

Mumbai Urban

Mumbai

Packaging Details

1 VIAL

1*10S

Carton Box.

Main Export Market(s)

Africa

Africa

Africa

Suitable For

Function

Dosage

dult and elderly patients The recommended dose of Letrozole Tablets is 2.5 mg once daily. No dose adjustment is required for elderly patients. In patients with advanced or metastatic breast cancer, treatment with Letrozole Tablets should continue until tumour progression is evident. In the adjuvant and extended adjuvant setting, treatment with Letrozole Tablets should continue for 5 years or until tumour relapse occurs, whichever is first. In the adjuvant setting a sequential treatment schedule (letrozole 2 years followed by tamoxifen 3 years) could also be considered (see sections 4.4 and 5.1). In the neoadjuvant setting, treatment with Letrozole tablet could be continued for 4 to 8 months in order to establish optimal tumour reduction. If the response is not adequate, treatment with Letrozole tablet should be discontinued and surgery scheduled and/or further treatment options discussed with the patient.

2.5 mg